# An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.

> **NCT00138749** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 402 (—)

## Conditions studied

- Urinary Incontinence, Stress

## Interventions

- **DRUG:** SS-RBX

## Key facts

- **NCT ID:** NCT00138749
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 402 (—)
- **Last updated:** 2011-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00138749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00138749, "An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00138749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*